Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |